Summit Therapeutics

Job Title: Manager, Upstream MSAT Department: Administration Location: Oxford, UK About Summit: Ivonescimab, known as SMT112, is a novel, potential first in class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD 1 with the anti…